Abstract:BACKGROUND:The complement system is one of the important contributing factors in the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). C5a and the neutrophil C5a receptor play a central role in antineutrophil cytoplasmic antibody (ANCA)-mediated neutrophil recruitment and activation. The current study further investigated the signaling pathways of C5a-mediated priming of human neutrophils for ANCA-induced neutrophil activation.METHODOLOGY/PRINCIPAL FINDINGS:The effects of the p38 mitogen-activated protein kinase (p38MAPK) inhibitor (SB202190), extracellular signal-regulated kinase (ERK) inhibitor (PD98059), c-Jun N-terminal kinase (JNK) inhibitor (6o) and phosphoinositol 3-kinase (PI3K) inhibitor (LY294002) were tested on respiratory burst and degranulation of C5a-primed neutrophils activated with ANCA, as well as on C5a-induced increase in expression of membrane-bound PR3 (mPR3) on neutrophils. For C5a-primed neutrophils for MPO-ANCA-induced respiratory burst, the mean fluorescence intensity (MFI) value was 254.8±67.1, which decreased to 203.6±60.3, 204.4±36.7, 202.4±49.9 and 188±47.9 upon pre-incubation with SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without inhibitors, P<0.01, P<0.05, P<0.01 and P<0.05), respectively. For PR3-ANCA-positive IgG, the MFI value increased in C5a-primed neutrophils, which decreased upon pre-incubation with above-mentioned inhibitors. The lactoferrin concentration increased in C5a-primed neutrophils induced by MPO or PR3-ANCA-positive IgG supernatant and decreased upon pre-incubation with above-mentioned three inhibitors. mPR3 expression increased from 923.3±182.4 in untreated cells to 1278.3±299.3 after C5a treatment and decreased to 1069.9±188.9, 1100±238.2, 1092.3±231.8 and 1053.9±200.3 by SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without inhibitors, P<0.01, P<0.05, P<0.01 and P<0.01), respectively.CONCLUSIONS/SIGNIFICANCE:Activation of p38MAPK, ERK and PI3K are important steps in the translocation of ANCA antigens and C5a-induced activation of neutrophils by ANCA.

Platelet Activation is Induced Via Myeloperoxidase Production and Anti-Myeloperoxidase Antibodies Primed by Thrombin

Influence of Myeloperoxidase by Anti-Myeloperoxidase Antibodies and Its Association with the Disease Activity in Microscopic Polyangiitis

Platelets Release Proinflammatory Microparticles in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.

Myeloperoxidase Influences The Complement Regulatory Function Of Modified C-Reactive Protein

Myeloperoxidase Influences the Complement Regulatory Activity of Complement Factor H.

Clinical and pathological study on 34 patients with primary ANCA-associated systemic vasculitis with renal immune complex deposition

Platelets Are Activated in ANCA-associated Vasculitis Via Thrombin-Pars Pathway and Can Activate the Alternative Complement Pathway.

Thrombin Contributes to Anti-myeloperoxidase Antibody Positive IgG-Mediated Glomerular Endothelial Cells Activation Through SphK1-S1P-S1PR3 Signaling

Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuli

High Potential to Reverse the Inhibition of Myeloperoxidase by Ceruloplasmin of Anti-Myeloperoxidase Autoantibodies of IgG3 Subclass

Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-associated Vasculitis

High Mobility Group Box-1 Contributes to Anti-Myeloperoxidase Antibody-Induced Glomerular Endothelial Cell Injury Through a Moesin-Dependent Route

Deglycosylation Influences the Oxidation Activity and Antigenicity of Myeloperoxidase

P38mapk, ERK and PI3K Signaling Pathways Are Involved in C5a-primed Neutrophils for ANCA-mediated Activation.

Influence of Myeloperoxidase-Catalyzing Reaction on the Binding Between Myeloperoxidase and Anti-Myeloperoxidase Antibodies

Comparison of Characteristics of Natural Autoantibodies Against Myeloperoxidase and Anti-Myeloperoxidase Autoantibodies from Patients with Microscopic Polyangiitis.

Deglycosylation of myeloperoxidase uncovers its novel antigenicity.

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?

Inhibition of Oxidative Activity of Myeloperoxidase by Anti-Myeloperoxidase Antibodies from Patients with Microscopic Polyangiitis

Myeloperoxidase induces monocyte migration and activation after acute myocardial infarction

The Interaction Between C5a and Sphingosine-1-Phosphate in Neutrophils for Antineutrophil Cytoplasmic Antibody Mediated Activation